BioLight Life Sciences Ltd (BOLT) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.137x

Based on the latest financial reports, BioLight Life Sciences Ltd (BOLT) has a cash flow conversion efficiency ratio of -0.137x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA-5.49 Million ≈ $-14.72K USD) by net assets (ILA40.17 Million ≈ $107.70K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

BioLight Life Sciences Ltd - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how BioLight Life Sciences Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read how much debt does BioLight Life Sciences Ltd carry for a breakdown of total debt and financial obligations.

BioLight Life Sciences Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of BioLight Life Sciences Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
E-Pango SA PA:ALAGO	0.796x
BPH Energy Ltd AU:BPH	-0.008x
NYRSTAR F:3NY1	N/A
T4F Entretenimento S.A SA:SHOW3	0.208x
T.Krungthai Industries Public Company Limited BK:TKT	0.037x
Equity Story Group Ltd AU:EQS	0.833x
Cambium Bio Ltd AU:CMB	-1.444x
Ajooni Biotech Limited NSE:AJOONI	0.149x

Annual Cash Flow Conversion Efficiency for BioLight Life Sciences Ltd (2012–2025)

The table below shows the annual cash flow conversion efficiency of BioLight Life Sciences Ltd from 2012 to 2025. For the full company profile with market capitalisation and key ratios, see BOLT market cap.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	ILA40.17 Million ≈ $107.70K	ILA-10.85 Million ≈ $-29.10K	-0.270x	+24.45%
2024-12-31	ILA30.74 Million ≈ $82.42K	ILA-10.99 Million ≈ $-29.47K	-0.358x	-13.15%
2023-12-31	ILA30.30 Million ≈ $81.24K	ILA-9.58 Million ≈ $-25.68K	-0.316x	-77.88%
2022-12-31	ILA53.69 Million ≈ $143.95K	ILA-9.54 Million ≈ $-25.58K	-0.178x	-8.84%
2021-12-31	ILA61.42 Million ≈ $164.66K	ILA-10.03 Million ≈ $-26.88K	-0.163x	+13.89%
2020-12-31	ILA60.11 Million ≈ $161.14K	ILA-11.39 Million ≈ $-30.55K	-0.190x	+15.87%
2019-12-31	ILA68.15 Million ≈ $182.70K	ILA-15.36 Million ≈ $-41.17K	-0.225x	+21.70%
2018-12-31	ILA77.80 Million ≈ $208.57K	ILA-22.39 Million ≈ $-60.03K	-0.288x	+90.87%
2017-12-31	ILA8.03 Million ≈ $21.53K	ILA-25.32 Million ≈ $-67.88K	-3.153x	-92.02%
2016-12-31	ILA16.41 Million ≈ $43.99K	ILA-26.94 Million ≈ $-72.23K	-1.642x	-221.44%
2015-12-31	ILA47.06 Million ≈ $126.17K	ILA-24.04 Million ≈ $-64.44K	-0.511x	+51.29%
2014-12-31	ILA25.74 Million ≈ $69.00K	ILA-26.99 Million ≈ $-72.35K	-1.049x	+11.60%
2013-12-31	ILA22.11 Million ≈ $59.27K	ILA-26.23 Million ≈ $-70.31K	-1.186x	-127.59%
2012-12-31	ILA37.34 Million ≈ $100.10K	ILA-19.46 Million ≈ $-52.17K	-0.521x	--

About BioLight Life Sciences Ltd

TA:BOLT Israel Biotechnology

Market Cap

$7.66 Million

ILA2.86 Billion ILA

Market Cap Rank

#27662 Global

#402 in Israel

Share Price

ILA315.60

Change (1 day)

+1.06%

52-Week Range

ILA217.90 - ILA604.90

All Time High

ILA3485.66